Long-Term Follow-up Results: A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed c-Kit Positive Acute Myeloid Leukemia (AML)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Advani, AS; Tse, W; Jia, X; Elson, P; Cooper, B; Ali-Osman, F; Park, J; Rao, AV; Rizzieri, DA; Wang, ES; Cotta, CV; Kalaycio, M; Sobecks, RM; Rouphail, B; Maciejewski, JP; Fensterl, J; Bailey, L; Carew, JS; Foster, B; Rush, ML; Adams, D; Griffiths, EA; Sekeres, MA

Published Date

  • December 3, 2015

Published In

Volume / Issue

  • 126 / 23

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971